Navigation Links
Medical research on ice
Date:6/12/2008

New medical equipment recently delivered to the Antarctic station Concordia will help understand how our bodies physically adapt to this extreme environment - knowledge which could help prepare for a future human mission to Mars. ESA is currently looking for a candidate with a medical background to support projects at the research base.

The Antarctic station Concordia is located in one of the most hostile environments on the Earth. Built on an ice plateau at 3 200 m altitude, exposed to extreme isolation, temperatures, constant light in summer, constant darkness in winter and other stressors, a stay at Concordia is a huge challenge.

Harsh winter

For the up to 16 crewmembers that can be hosted in the station during the Antarctic winter, conditions are even more severe as the harsh environmental conditions make access to or from the station impossible. Any problems that occur need to be dealt with autonomously by the crew with the resources at hand.

Fortunately for ESA, many of the same constraints that naturally occur during the winter at Concordia are quite similar to those that can be expected for future crewed exploration missions, for example to Mars.

For this reason, in 2002, ESA established a cooperation with the builders and operators of the station; the French Polar Institute (Institute Paul Emile Victor, IPEV) and the Italian Antarctic Programme (Consorzio per l'Attuazione del Programma Nazionale di Ricerche in Antartide, PNRA S.C.r.l.). Next to some technology validation, the main focus of this cooperation is on medicine, physiology and psychology.

Long-Term Medical Survey

Together with the Concordia partners and a diverse group of experts, ESA has defined the Long-Term Medical Survey (LTMS); a list of physiological and psychological parameters that is collected by each Concordia crewmember, with the goal of enhancing knowledge about human adaptation in this extreme environment.

To facilitate the collection of physiological data, ESA commissioned the development of an easy-to-use, minimally intrusive, integrated monitoring device, taking into account that the majority of Concordia crewmembers have no medical background. The first prototype was recently shipped to Antarctica and is now being evaluated by the Concordia crew.

Other interesting medical and psychological research is still ongoing at the station. For example, a current project investigates how blood clotting is affected by the high altitude at Concordia. This research is very relevant to understanding the 'economy class syndrome' - the risk of thrombosis when flying long-distance in airplanes. The psychological projects look for example at how the crew adapts to the extreme environment, or how they cope with the challenging situation. This type of research will also continue throughout the coming winter season.


'/>"/>

Contact: Markus Bauer
markus.bauer@esa.int
31-715-656-799
European Space Agency
Source:Eurekalert

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
Breaking Medicine Technology: